Syringe and paper moneyDr. Paul Offit has written another pro-vaccine screed for this powerful publication without one word about all the money he has made as a vaccine developer. Action Alert! The opinion piece, published this week, talks about respiratory infections “making a comeback” (had they really gone away?) and lays the problem at the… Continue reading Wall Street Journal Apparently Doesn’t Care About Blatant Medical Conflicts of Interest
Month: September 2014
GE Wheat Contamination in Montana Proves GMOs Can’t Be Controlled
The USDA’s response is to talk out of both sides of their mouth. In a single press release, the USDA closes its investigation of the contamination of wheat fields in Oregon, calling it an “isolated incident,” then immediately contradicts itself by opening another investigation into contamination from genetically engineered wheat. The contamination was found at… Continue reading GE Wheat Contamination in Montana Proves GMOs Can’t Be Controlled
Who Is the Number One Foe of Supplements on Capitol Hill?
Now that Henry Waxman is retiring from Congress, it is clearly Senator Dick Durbin (D-IL). State Action Alert! Sen. Durbin has long demonstrated a bias against dietary supplements. Here’s a taste of his career-long attempt to give FDA the power to sweep thousands of supplements off the shelves: In 2004, Sen. Durbin proposed an amendment… Continue reading Who Is the Number One Foe of Supplements on Capitol Hill?
FDA, Flooded with Protests, Revises Food Safety Rules
The agency has responded to comments from ANH-USA activists and other stakeholders. Here’s what they’re proposing now. Action Alert! In May we reported that the FDA is currently drafting rules that implement the 2011 Food Safety Modernization Act (FSMA). As we noted then, some of the rules that have been proposed so far have brought… Continue reading FDA, Flooded with Protests, Revises Food Safety Rules
Dr. Einsteinburger’s PSA
Dr. Einsteinburger, scientific director of Biosantech (no relation to any real biotech companies located in the St. Louis area), elaborates on the latest innovations by the leader in biotech.
FDA Approves Controversial Diet Drug Despite Warning of Suicide Risk
Contrave has terrible side effects, is expensive, includes a hidden antidepressant, and barely even works. So why did the FDA approve it? Action Alert! The FDA approved two weight loss drugs in 2012, Qsymia and Belviq, but sales have been sluggish. This week FDA approved Contrave, even though the FDA initially denied approval to Contrave in… Continue reading FDA Approves Controversial Diet Drug Despite Warning of Suicide Risk
Congressional Committee Says FDA Is Overstepping Its Jurisdiction
A powerful subcommittee says a new FDA proposal on medical testing will stifle innovation and may not be legal. Action Alert! Three months ago we told you about laboratory-developed tests (LDTs)—inexpensive diagnostic tests for patients that are developed and performed by local labs. They include standard tests but also new ones, genetic tests, tests for… Continue reading Congressional Committee Says FDA Is Overstepping Its Jurisdiction
FDA Approves Controversial Diet Drug Despite Warning of Suicide Risk
Contrave has terrible side effects, is expensive, includes a hidden antidepressant, and barely even works. So why did the FDA approve it?
ANH Honored at Awards Gala
EMORD & ASSOCIATES HONORS LEADERS IN NUTRITION, INTEGRATIVE MEDICINE, MEDICAL SCIENCE, AND JOURNALISM AT SPECTACULAR GALA Cambridge, Maryland—On September 5 and 6, 2014, the constitutional and administrative law firm Emord & Associates, P.C. held a spectacular celebration and awards program at the Hyatt Regency Resort on the occasion of its 20th anniversary and in honor of George… Continue reading ANH Honored at Awards Gala